Oct 2026
Survodutide Once Weekly in Adults with Obesity and Type 2 Diabetes.
BACKGROUND For persons living with both type 2 diabetes and obesity, weight management may be the most effective therapy for type 2 diabetes. Glucagon-like peptide-1 (GLP-1) receptor agonists have potent weight-reducing effects, and other mechanisms may confer additional benefits. Survodutide is an investigational gluc...
Sean Wharton, C. L. le Roux, E. Startseva et al.
· New England Journal of Medic... · 0 citations